INRA, UR1282, Infectiologie Animale et Sante Publique, IASP, Nouzilly, F-37380, France.
Front Biosci (Landmark Ed). 2010 Jan 1;15(2):550-63. doi: 10.2741/3633.
A misfolded isoform of the prion protein (PrP) is the essential component of the prion diseases' agent. The prion concept has progressively gained acceptance, in a large part thanks to the realization that it played a role not only in the transmissible spongiform encephalopathies, but also in the non-Mendelian propagation of self-perpetuating phenotypes of the yeast Saccharomyces cerevisiae. Uncertainties about the nature of the agent and the function of PrP have fostered searches of nucleic acid ligands of the protein. In vitro methods of nucleic acid evolutions have been used to identify RNAs or DNAs that bind PrP, towards the triple objective of i) setting up new diagnostic tools, ii) identifying nucleic acids with which PrP may interact, as part of its physiological or pathological function, and iii) elucidating the pathological transconformation of PrP. This review will focus on these studies, their methods, the knowledge acquired from them about the prion protein, and the possibilities that they offer in the areas of diagnosis and therapy of prion diseases.
一种错误折叠的朊病毒蛋白(PrP)异构体是朊病毒疾病的主要成分。朊病毒的概念逐渐被人们接受,这在很大程度上要归功于人们意识到它不仅在传染性海绵状脑病中发挥作用,而且在酵母酿酒酵母中非孟德尔遗传的自我维持表型的传播中也发挥作用。对病原体的性质和 PrP 功能的不确定性促进了对该蛋白核酸配体的研究。体外核酸进化方法已被用于鉴定与 PrP 结合的 RNA 或 DNA,以达到三个目标:i)建立新的诊断工具,ii)鉴定与 PrP 相互作用的核酸,作为其生理或病理功能的一部分,以及 iii)阐明 PrP 的病理性转化。本文将重点介绍这些研究及其方法,以及它们在朊病毒疾病的诊断和治疗领域提供的可能性。